Picard Medical, Inc. (PMI): who owns it and who trades it
As of Nov 16, 2026, no open-market insider purchases or sales of PMI were reported in the last 12 months. 1 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Insider trades
No PMI insider reported an open-market purchase or sale in the last 12 months.
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
PMI short interest
74,420 PMI shares are sold short. Over the last 12 reports the number of shares short went down 84%.
As of Oct 30, 2026, 74,420 PMI shares were sold short, up 44.9% from the report before. At the average daily volume of 410,772 shares, buying them all back would take about 1.0 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 74,420 | – | +45% | 410,772 | 1.0 |
| Oct 15, 2026 | 51,356 | – | +36% | 690,919 | 1.0 |
| Sep 30, 2026 | 37,672 | 0.05% | -84% | 113,599 | 1.0 |
| Sep 15, 2026 | 231,853 | 0.31% | -35% | 541,414 | 1.0 |
| Aug 31, 2026 | 358,385 | 0.48% | +369% | 7.69M | 1.0 |
| Aug 14, 2026 | 76,345 | 0.10% | -98% | 116,352 | 1.0 |
| Jul 31, 2026 | 3.73M | 4.96% | -76% | 6.90M | 1.0 |
| Jul 15, 2026 | 15.40M | 20.48% | +358% | 55.75M | 1.0 |
| Jun 30, 2026 | 3.36M | 4.47% | +11% | 4.59M | 1.0 |
| Jun 15, 2026 | 3.03M | 4.03% | +125% | 114.03M | 1.0 |
| May 29, 2026 | 1.35M | 1.79% | +183% | 45.65M | 1.0 |
| May 15, 2026 | 475,224 | 0.63% | -57% | 4.32M | 1.0 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Picard Medical company events
Picard Medical filed 41 reports on Form 8-K in the last 12 months, 8 of them about an important change (leadership, listing). The latest was on Nov 3, 2026.
- Nov 3, 2026LeadershipThe Board of Directors of Picard Medical, Inc., a Delaware company appointed Richard Fang, Ph.D., as the Company’s Chief Executive Officer on a permanent, full-time basis, effective as of the same date. Filing
- Oct 23, 2026AgreementPicard Medical, Inc. entered into a Warrant Amendment and Exchange Agreement with the placement agent of its private placement closed on December 26, 2025, and such Warrant Holder’s employee designee (“Designee”, together with the Warrant Holder, “Warrant Holders”) as a party by joinder who is… Filing
- Oct 13, 2026RulesChanged its bylaws or articles. Filing
- Oct 6, 2026DebtTook on new debt. Filing
- Aug 20, 2026AnnouncementShared information with investors. Filing
- Jul 27, 2026ListingPicard Medical, Inc. received a letter from the NYSE American LLC stating that the NYSE American has accepted the Company's plan to regain compliance with the NYSE American’s continued listing standards, specifically Sections 1003(a)(i) and (ii) since, as previously disclosed in Current Reports on… Filing
- Jul 22, 2026AnnouncementAlso on July 21, 2026, the Company issued a press release announcing the approval of the Reverse Stock Split. Filing
- Jul 21, 2026VoteReported shareholder vote results. Filing
- Jul 13, 2026AnnouncementAmended an earlier report. The Company filed the Original Form 8-K to announce the availability of a pre-recorded presentation in advance of the Company's 2026 Annual Meeting of Stockholders, scheduled for July 17, 2026. Filing
- Jul 7, 2026LeadershipAmended an earlier report. Picard Medical, Inc. filed a Current Report on Form 8-K with the SEC on June 26, 2026, reporting the appointment of Dr. Joe Xiao to the Company's Board of Directors and certain committees thereof. Filing
- Jul 2, 2026AnnouncementAs previously disclosed in Picard Medical, Inc.'s Current Report on Form 8-K filed on July 2, 2026, the Company published a pre-recorded presentation providing stockholders with an overview of the Company's recent business performance, product development progress, manufacturing initiatives, and… Filing
- Jul 2, 2026AnnouncementMade another announcement. Filing
- Jun 29, 2026LeadershipDr. Joe Xiao was appointed to the Board of Directors of Picard Medical, Inc. with a term set to expire at the 2026 annual meeting of stockholders. Filing
- Jun 24, 2026LeadershipPatrick NJ Schnegelsberg notified Picard Medical, Inc. of his decision to step down as Chief Executive Officer and as a member of the Board of Directors of the Company, effective June 18, 2026, in connection with a planned leadership transition. Filing
- Jun 2, 2026LeadershipAlso as of June 1, 2026, Bernard Skaggs was terminated as the Chief Financial Officer of Picard Medical, Inc., effective immediately. Filing
- May 29, 2026AnnouncementShared information with investors. Filing
- May 21, 2026ListingThe Company received a written notice from the NYSE American LLC indicating that the Company is not in compliance with the NYSE American continued listing standards set forth in Section 1003(a)(i) of the NYSE American Company Guide, which requires a listed company to have stockholders’ equity of at… Filing
- May 11, 2026ListingThe Company received a written notice from the NYSE American LLC indicating that the Company is not in compliance with the NYSE American continued listing standards set forth in Section 1003(a)(ii) of the NYSE American Company Guide requiring a company to have stockholders’ equity of at least $4.0… Filing
- May 5, 2026AgreementPicard Medical, Inc. entered into a Warrant Issuance and Exchange Agreement with the holder of certain of the Company’s outstanding warrants to purchase shares of the Company’s common stock, par value $0.0001 per share. Filing
- Apr 22, 2026ResultsReleased financial results. Filing
- Apr 13, 2026AgreementPicard Medical, Inc. entered into a securities purchase agreement with Quick Capital, LLC, a Wyoming limited liability company, an accredited investor, for the issuance and sale of a convertible promissory note in the principal face amount of $555,555.56 and 80,128 shares of the Company’s common… Filing
- Mar 27, 2026AnnouncementShared information with investors. Filing
- Mar 25, 2026ResultsReleased financial results. Filing
- Mar 20, 2026AnnouncementShared information with investors. Filing
- Mar 19, 2026AnnouncementShared information with investors. Filing
- Mar 17, 2026AnnouncementShared information with investors. Filing
- Mar 16, 2026VoteReported shareholder vote results. Filing
- Mar 13, 2026AnnouncementShared information with investors. Filing
- Mar 13, 2026AnnouncementShared information with investors. Filing
- Mar 2, 2026AnnouncementShared information with investors. Filing
- Feb 26, 2026AnnouncementShared information with investors. Filing
- Jan 13, 2026AnnouncementShared information with investors. Filing
- Jan 13, 2026AnnouncementShared information with investors. Filing
- Dec 30, 2025AgreementPicard Medical, Inc., entered into a securities purchase agreement with a single institutional investor, pursuant to which the Company agreed to issue and sell, in a private placement exempt from registration under the Securities Act of 1933, as amended, and Rule 506(b) of Regulation D, promulgated… Filing
- Dec 18, 2025AnnouncementShared information with investors. Filing
- Dec 9, 2025AnnouncementShared information with investors. Filing
- Dec 4, 2025AnnouncementShared information with investors. Filing
- Dec 3, 2025AnnouncementShared information with investors. Filing
- Nov 26, 2025AgreementPicard Medical, Inc., a Delaware corporation entered into a short-term bridge financing in the form of an unsecured promissory note with Fang Family Fund, LLC, an affiliate of Mr. Richard Fang, the Chairman of the Company’s Board of Directors, pursuant to which FFF I agreed to lend the Company an… Filing
- Nov 26, 2025AnnouncementShared information with investors. Filing
- Nov 19, 2025AnnouncementShared information with investors. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Famous investors that hold PMI
1 of the 50 well-known investors we track reported holding PMI in their latest 13F filing. The largest position is Ken Griffin's, worth $68.9K.
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Ken Griffin · Citadel Advisors | Q3 2026 | 16,402 | $68.9K | 0.0% | New |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
Questions about Picard Medical, Inc. (PMI) stock
Are PMI insiders buying or selling?
No PMI insider reported an open-market purchase or sale on Form 4 in the last 12 months. Share awards, option exercises and gifts are not counted.
What is the short interest in PMI?
As of Oct 30, 2026, 74,420 PMI shares were sold short, up 44.9% from the report before. At the average daily volume of 410,772 shares, buying them all back would take about 1.0 trading days (days to cover). See the history.
Which famous investors hold PMI?
1 of the 50 well-known investors we track reported PMI in their latest 13F filing, including Ken Griffin. The largest position is worth $68.9K. See all holders.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.